Last reviewed · How we verify
TDM-105795, 0.0025%
TDM-105795, 0.0025% is a Small molecule drug developed by Technoderma Medicines Inc.. It is currently in Phase 2 development.
At a glance
| Generic name | TDM-105795, 0.0025% |
|---|---|
| Sponsor | Technoderma Medicines Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia (PHASE2)
- A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA) (PHASE1)
- A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TDM-105795, 0.0025% CI brief — competitive landscape report
- TDM-105795, 0.0025% updates RSS · CI watch RSS
- Technoderma Medicines Inc. portfolio CI
Frequently asked questions about TDM-105795, 0.0025%
What is TDM-105795, 0.0025%?
TDM-105795, 0.0025% is a Small molecule drug developed by Technoderma Medicines Inc..
Who makes TDM-105795, 0.0025%?
TDM-105795, 0.0025% is developed by Technoderma Medicines Inc. (see full Technoderma Medicines Inc. pipeline at /company/technoderma-medicines-inc).
What development phase is TDM-105795, 0.0025% in?
TDM-105795, 0.0025% is in Phase 2.
Related
- Manufacturer: Technoderma Medicines Inc. — full pipeline
- Compare: TDM-105795, 0.0025% vs similar drugs
- Pricing: TDM-105795, 0.0025% cost, discount & access